Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_3
2
15%
Ph phase_2
5
38%
Ph phase_4
2
15%
Ph not_applicable
4
31%

Phase Distribution

0

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
5(38.5%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
4(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(8)
Terminated(1)
Other(4)

Detailed Status

Completed8
unknown4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (38.5%)
Phase 32 (15.4%)
Phase 42 (15.4%)
N/A4 (30.8%)

Trials by Status

unknown431%
withdrawn18%
completed862%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13